Open AccessP17.32 * EFFICACY AND TOLERABILITY OF BEVACIZUMAB MONOTHERAPY IN PATIENTS WITH PREVIOUSLY TREATED RECURRENT GLIOBLASTOMA MULTIFORME (GBM)
Author(s) -
Edoardo Francini,
Silvia Mazzaroppi,
Maurizio Salvati,
S Caponnetto,
Letizia Laera,
Cristina Migali,
Vincenzo Bianco
Publication year - 2014
Publication title -
neuro-oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 4.005
H-Index - 125
eISSN - 1523-5866
pISSN - 1522-8517
DOI - 10.1093/neuonc/nou174.361
Subject(s) - tolerability , medicine , bevacizumab , common terminology criteria for adverse events , toxicity , oncology , vascular endothelial growth factor , adverse effect , gastroenterology , chemotherapy , vegf receptors
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom